In vivo brain microdialysis studies on the striatal dopamine and serotonin release in zitter mutant rats. 2006

Kanji Yoshimoto, and Akira Nishimura, and Hiroyuki Hattori, and Jeffery N Joyce, and Toshihide Yoshida, and Chizuko Hioki, and Akinori Kogure, and Shuichi Ueda
Department of Legal Medicine, Kyoto Prefectural University of Medicine, Kawaramachi, Kamigyo-ku, Kyoto 602-8566, Japan. kyoshimo@koto.kpu-m.ac.jp

In the present study, using in vivo brain microdialysis, we investigated the basal extracellular dopamine (DA) and serotonin (5-HT) release in the caudal striatum (cSTR) of young (4-6 months old) and aged (10-12 months old) zitter mutant rats. The basal extracellular levels of DA release in both young and aged zitter rats were significantly lower than that of age-matched Sprague-Dawley (SD) rats, whereas only aged zitter rats showed a significant difference in the basal 5-HT release. Dopaminergic neurons were more vulnerable than serotonergic neurons in the cSTR of zitter mutant rats during aging. Perfusion of 60 mM potassium (K+) enhanced the extracellular levels of cSTR DA in the young zitter rats and the extracellular levels of both DA and 5-HT in the cSTR of the aged zitter rats. The firing rate of K+-stimulated monoamine release in the cSTR was significantly higher in the zitter rats than in the age-matched SD rats. These findings suggest that there are innate quantitative differences in the releasable pool and the availability of monoamines in the cSTR of zitter mutant rats.

UI MeSH Term Description Entries
D010291 Paresis A general term referring to a mild to moderate degree of muscular weakness, occasionally used as a synonym for PARALYSIS (severe or complete loss of motor function). In the older literature, paresis often referred specifically to paretic neurosyphilis (see NEUROSYPHILIS). "General paresis" and "general paralysis" may still carry that connotation. Bilateral lower extremity paresis is referred to as PARAPARESIS. Hemiparesis,Muscle Paresis,Brachial Paresis,Crural Paresis,Lower Extremity Paresis,Monoparesis,Muscular Paresis,Upper Extremity Paresis,Brachial Pareses,Crural Pareses,Extremity Pareses, Lower,Extremity Pareses, Upper,Extremity Paresis, Lower,Extremity Paresis, Upper,Hemipareses,Lower Extremity Pareses,Monopareses,Muscle Pareses,Muscular Pareses,Pareses,Pareses, Brachial,Pareses, Crural,Pareses, Lower Extremity,Pareses, Muscle,Pareses, Muscular,Pareses, Upper Extremity,Paresis, Brachial,Paresis, Crural,Paresis, Lower Extremity,Paresis, Muscle,Paresis, Muscular,Paresis, Upper Extremity,Upper Extremity Pareses
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D011922 Rats, Mutant Strains Rats bearing mutant genes which are phenotypically expressed in the animals. Mutant Strains Rat,Mutant Strains Rats,Rat, Mutant Strains,Strains Rat, Mutant,Strains Rats, Mutant
D001923 Brain Chemistry Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states. Chemistry, Brain,Brain Chemistries,Chemistries, Brain
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001523 Mental Disorders Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function. Mental Illness,Psychiatric Diseases,Psychiatric Disorders,Psychiatric Illness,Behavior Disorders,Diagnosis, Psychiatric,Mental Disorders, Severe,Psychiatric Diagnosis,Illness, Mental,Mental Disorder,Mental Disorder, Severe,Mental Illnesses,Psychiatric Disease,Psychiatric Disorder,Psychiatric Illnesses,Severe Mental Disorder,Severe Mental Disorders

Related Publications

Kanji Yoshimoto, and Akira Nishimura, and Hiroyuki Hattori, and Jeffery N Joyce, and Toshihide Yoshida, and Chizuko Hioki, and Akinori Kogure, and Shuichi Ueda
April 1998, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity,
Kanji Yoshimoto, and Akira Nishimura, and Hiroyuki Hattori, and Jeffery N Joyce, and Toshihide Yoshida, and Chizuko Hioki, and Akinori Kogure, and Shuichi Ueda
February 1988, The American journal of physiology,
Kanji Yoshimoto, and Akira Nishimura, and Hiroyuki Hattori, and Jeffery N Joyce, and Toshihide Yoshida, and Chizuko Hioki, and Akinori Kogure, and Shuichi Ueda
September 1990, Journal of neuroscience methods,
Kanji Yoshimoto, and Akira Nishimura, and Hiroyuki Hattori, and Jeffery N Joyce, and Toshihide Yoshida, and Chizuko Hioki, and Akinori Kogure, and Shuichi Ueda
July 1991, European journal of pharmacology,
Kanji Yoshimoto, and Akira Nishimura, and Hiroyuki Hattori, and Jeffery N Joyce, and Toshihide Yoshida, and Chizuko Hioki, and Akinori Kogure, and Shuichi Ueda
June 1985, Life sciences,
Kanji Yoshimoto, and Akira Nishimura, and Hiroyuki Hattori, and Jeffery N Joyce, and Toshihide Yoshida, and Chizuko Hioki, and Akinori Kogure, and Shuichi Ueda
January 2002, Synapse (New York, N.Y.),
Kanji Yoshimoto, and Akira Nishimura, and Hiroyuki Hattori, and Jeffery N Joyce, and Toshihide Yoshida, and Chizuko Hioki, and Akinori Kogure, and Shuichi Ueda
April 1993, Brain research,
Kanji Yoshimoto, and Akira Nishimura, and Hiroyuki Hattori, and Jeffery N Joyce, and Toshihide Yoshida, and Chizuko Hioki, and Akinori Kogure, and Shuichi Ueda
January 1994, Journal of neurochemistry,
Kanji Yoshimoto, and Akira Nishimura, and Hiroyuki Hattori, and Jeffery N Joyce, and Toshihide Yoshida, and Chizuko Hioki, and Akinori Kogure, and Shuichi Ueda
September 1994, The Journal of pharmacology and experimental therapeutics,
Kanji Yoshimoto, and Akira Nishimura, and Hiroyuki Hattori, and Jeffery N Joyce, and Toshihide Yoshida, and Chizuko Hioki, and Akinori Kogure, and Shuichi Ueda
August 1991, Journal of neurochemistry,
Copied contents to your clipboard!